false
Catalog
Regulatory Issues and Medications for Opioid Use D ...
Presentation
Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Brian Hurley, an Addiction Psychiatrist, discusses the regulatory issues and medications for opioid use disorder. He explains that the goal of the Provider Clinical Support System is to train healthcare professionals in evidence-based practices for the prevention and treatment of opioid use disorder. He discusses the legal differences between an opioid treatment program, hospital-managed medications for opioid use disorder, and office-based opioid treatment. He also talks about X-waivered clinicians and how they can increase the number of patients they can treat with buprenorphine medications. He reviews the rules regulating the treatment of opioid use disorder with buprenorphine and methadone and discusses the confidentiality rules governing substance use treatment records. He also demonstrates how to appropriately manage medications for opioid use disorder using telemedicine. He goes on to outline the Controlled Substances Act, the Drug Addiction Treatment Act of 2000, the Comprehensive Addiction Recovery Act of 2016, and the SUPPORT Act of 2018. He explains the laws and regulations governing the use of different medications for opioid use disorder, such as buprenorphine, methadone, and extended-release naltrexone injections. He also discusses the limitations and requirements for X-waivered clinicians and opioid treatment programs. Lastly, he covers the confidentiality regulations under 42 CFR Part 2 and the telemedicine guidelines for prescribing medications for opioid use disorder. The video provides a comprehensive overview of the regulatory environment surrounding medications for opioid use disorder. No credits were mentioned.
Asset Subtitle
View the recorded presentation to attest that you have viewed the presentation in its entirety.
Keywords
Addiction Psychiatrist
regulatory issues
medications
opioid use disorder
Provider Clinical Support System
evidence-based practices
treatment
confidentiality regulations
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English